Pharmacokinetic interaction between the proton pump inhibitor omeprazole and the HIV protease inhibitor indinavir.
Burger
D M
DM
Hugen
P W
PW
Kroon
F P
FP
Groeneveld
P
P
Brinkman
K
K
Foudraine
N A
NA
Sprenger
H
H
Koopmans
P P
PP
Hekster
Y A
YA
D019380:Anti-HIV Agents / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D002851:Chromatography, High Pressure Liquid; D004791:Enzyme Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006801:Humans; D019469:Indinavir / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D009853:Omeprazole / Q000493:pharmacokinetics* / Q000627:therapeutic use; D054328:Proton Pump Inhibitors
D019380:Anti-HIV Agents; D004791:Enzyme Inhibitors; D017320:HIV Protease Inhibitors; D054328:Proton Pump Inhibitors; D019469:Indinavir; D009853:Omeprazole